2Aydin A,Ioannis M,Matalliotakis MD,et al.Diagnostic role of inhibin B in resistant ovary syndrome associated with secondary amenorrhea[J].Fertil Steril,2002,78(6):1324-1326.
1Biller BM, Luciano A, Crosignani PG,et al. Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med, 1999, 44[12 Suppl]:1075-1084.
2Andrews ZB, Grattan DR. Opioid receptor subtypes involved in the regulation of prolactin secretion during pregnancy and lactation. J Neuroendocrinol, 2003, 15(3):227-236.
3Phelps JY, Bugg EM, Shamblott MJ, et al. Prolaction gene expression in human ovarian follicular cells. Fertil Steril, 2003, 79(1):182-185.
4Vera-Lastra O, Luis J, Luis R, et al. Prolactin and autoimmun. Autoimmun Rev, 2002, 1:360-364.
5Serri O, Chik CL, Ur E, et al, Diagnosis and management of hyperprolactinemia. CMAJ, 2003, 169(6):575-581.
6Emiliano AB, Fudge JL, From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions. Neuropsychopharmacology, 2004, 29(5):833-846.
7Gurlek A, Nar A, Gedik O. Isolated adrenocorticotropic hormone deficiency, thyroid autoimmunity, and transient hyperprolactinemia. Endocr Pract, 2001, 7(2):102-105.
8Inoue A, Seto M, Sugita S, et al, Differential effects on D2 doparnine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary. Brain Res Mol Brain Res, 1998, 55(2):285-289.
9Valdemarsson S. Macroprolactinemia: Risk of misdiagnosis and mismanagement in hyperprolactinemia. Lakartidningen, 2004, 101 (6):458-465.
10Vallette-Kasic S, Morange-Ramos I, Selim A, et al. Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab, 2002,87:581-588.
2Laml T. Sehulz-Lobmeyr I, Obruca A, et al . Premature o- varian failure: etiology and prospects [J]. Gynecol Endocrinol, 2000, 14(4) : 292-302.
3Trepanowski JF, Kabir MM, Alleman RJ, et al. A 21-day Daniel fast with or without krill oil supplementation improves anthropometric parameters and the cardiometabolic profile in men and women[J]. Nutr Metab (Lond) ,2012, 9(1):82.
4Shi K, Ugi S, Shimizu S, et al. Membrane localization of protein tyrosine phosphatase 1B is essential for its activation of sterol regulatory element-binding protein-1 gene expression [J]. Biochem Biophys Res Commun ,2007, 363(3) :626-632.
5Ugi S, Shi K, Nishio Y, et al. Membrane localization of protein-tyrosine pbosphatase 1B is essential for its activation of sterol regulatory element- binding protein-1 gene expres- sion and consequent hypertriglyceridaemia [J]. J Biochem , 2009, 146(4) :541-547.
6Lee W, Yoon G, Hwang YR, et al. Anti obesity and hypo lipidemic effects of Rheum undulatum in high-fat diet-fed C57BL/6 mice through protein tyrosine phosphatase 1B inhi- bition [J]. BMB Rep ,2012, 45(3):141-146.
7Kaszubska W, Falls HD, Schaefer VG, et al . Protein tyro- sine phosphatase 1B negatively regulates leptin signaling in a hypothalamie cell line [J]. Mol Cell Endocrinol , 2002, 195 (12):109 -118.
8Tsou RC, Zimmer DJ, De Jonghe BC, et al . Deficiency of PTPIB in leptin receptor-expressing neurons leads to de- creased body weight and adiposity in mice [ J ]. Endocrinology ,2012, 153(9) :4227-4237.
9ELIA E M,BELGOROSKY D,FAUT M,et al.The effects of metformin on uterine tissue of hyperandrogenized BALB/c mice[J].Mol Hum Reprod,2009,15(7):421-432.
